Papers - Sugimoto, Yoshikazu

Regulations of P-Glycoprotein/ABCB1/MDR1 in Human Cancer Cells

Katayama K, Noguchi K, Sugimoto Y.

New Journal of Science (Hindawi Publishing Corporation)  2014   476974 2015.05

Research paper (scientific journal), Joint Work, Accepted

Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.

Saeed M, Kadioglu O, Khalid H, Sugimoto Y, Efferth T.

J Nutr Biochem. (Elsevier)  26 ( 1 ) 44 - 56 2015.01

Research paper (scientific journal), Joint Work, Accepted

Suppression of γ-irradiation-induced deletion mutations under Parp-1 deficiency in mice.

Wang J, Abe M, Sasamoto E, Maeda D, Sugimoto Y, Miki Y, Masutani M.

Scholars Acad J Biosci 3 ( 12 ) 998 - 1004 2015

Research paper (scientific journal), Joint Work, Accepted

Resistance mechanisms of cancer cells to the novel vacuolar H+-ATPase inhibitor archazolid B.

Hamm R, Sugimoto Y, Steinmetz H, Efferth T.

Invest New Drugs (Springer)  32 ( 5 ) 893 - 903 2014.10

Research paper (scientific journal), Joint Work, Accepted

The lignan, (-)-sesamin reveals cytotoxicity toward cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance.

Saeed M, Khalid H, Sugimoto Y, Efferth T.

Phytomedicine (Elsevier)  21 ( 5 ) 689 - 696 2014.04

Research paper (scientific journal), Joint Work, Accepted

Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function.

Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y.

Cancer Letters 345 ( 1 ) 124 - 131 2014.04

Research paper (scientific journal), Joint Work, Accepted

Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function.

Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y*.

Cancer Letters 345   p 124-131 2014.04

Research paper (scientific journal), Joint Work, Accepted

The lignan, (-)-sesamin reveals cytotoxicity toward cancer cells: Pharmacogenomic determination of genes associated with sensitivity or resistance.

Saeed M, Khalid H, Sugimoto Y, Efferth T.

Phytomedicine 21(5)   689-696 2014.04

Research paper (scientific journal), Joint Work, Accepted

Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics.

Noguchi K, Katayama K, Sugimoto Y.

Pharmacogenomics and Personalized Medicine 7   53 - 64 2014.02

Research paper (scientific journal), Accepted

Biochemical Interaction of Anti-HCV Telaprevir with the ABC Transporters P-glycoprotein and Breast Cancer Resistance Protein.

Fujita Y, Noguchi K*, Suzuki T, Katayama K, Sugimoto Y.

BMC Research Notes 6   445 2013.11

Research paper (scientific journal), Joint Work, Accepted

FBXO15 regulates P-glycoprotein/ABCB1 expression through the ubiquitin-proteasome pathway in cancer cells.

Katayama K, Noguchi K, Sugimoto Y*.

Cancer Science 104   694-702 2013.06

Research paper (scientific journal), Joint Work, Accepted

Human decidua-derived mesenchymal cells is a promising source for generation and cell banking of human induced pluripotent stem cells.

Shofuda T, Kanematsu D, Fukusumi H, Yamamoto A, Bamba Y, Yoshitatsu S, Suemizu H, Nakamura M, Sugimoto Y, Furue M, Kohara A, Akamatsu W, Okada Y, Okano H, Yamasaki M, Kanemura Y*.

Cell Medicine 4(3)   125-147 2013.05

Research paper (scientific journal), Joint Work, Accepted

Expression of human ABCB5 confers resistance to taxanes and anthracyclines.

Kawanobe T, Kogure S, Nakamura S, Sato M, Katayama K, Mitsuhashi J, Noguchi K, Sugimoto Y*.

Biochemical and Biophysical Research Communications 418   736-41 2012.03

Research paper (scientific journal), Joint Work, Accepted

Novel regulatory role for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP in chemosensitization to bleomycin.

Masuda Y, Noguchi K*, Segawa H, Tanaka N, Katayama K, Mitsuhashi J, Sugimoto Y.

Biochemical and Biophysical Research Communications 415   305-12 2011.12

Research paper (scientific journal), Joint Work, Accepted

DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.

Yasuda A, Noguchi K*, Minoshima M, Kashiwazaki G, Kanda T, Katayama K, Mitsuhashi J, Bando T, Sugiyama H, Sugimoto Y.

Cancer Science 102   2221-30 2011.12

Research paper (scientific journal), Joint Work, Accepted

Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.

Yamazaki R*, Nishiyama Y, Furuta T, Hatano H, Igarashi Y, Kodaira H, Takahashi H, Aiyama R, Matsuzaki T, Yagi N, Sugimoto Y.

Molecular Cancer Therapeutics 10(7)   1252-1263 2011.07

Research paper (scientific journal), Joint Work, Accepted

BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization.

Shigeta J, Katayama K, Mitsuhashi J, Noguchi K, Sugimoto Y*.

Cancer Science 101   1813-1821 2010.08

Research paper (scientific journal), Joint Work, Accepted

In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate.

Mitsuhashi J, Hosoyama H, Tsukahara S, Katayama K, Noguchi K, Ito Y, Hatake K, Aiba K, Takahashi S, Sugimoto Y*.

Journal of Gene Medicine 12   596-603 2010.07

Research paper (scientific journal), Joint Work, Accepted

Pharmacological interaction with sunitinib is abolished by a germ line mutation (1291T>C) of BCRP/ABCG2 gene.

Kawahara H, Noguchi K, Katayama K, Mitsuhashi J, Sugimoto Y*.

Cancer Sci 101(6)   1493-1500 2010.06

Research paper (scientific journal), Joint Work, Accepted

Functional availability of gamma-herpesvirus K-cyclin is regulated by cellular CDK6 and p16INK4a.

Yoshioka H, Noguchi K, Katayama K, Mitsuhashi J, Yamagoe S, Fujimuro M, Sugimoto Y*.

Biochem Biophys Res Commun 394(4)   1000-1005 2010.03

Research paper (scientific journal), Joint Work, Accepted